Ermenegildo Zegna NV
ZGN
Hutchmed (China)
HCM
Enerpac Tool
EPAC
4
eBay
EBAY
5
YETI Holdings
YETI
US Stock MarketDetailed Quotes
BIVI BioVie
- 1.070
- +0.025+2.39%
Trading Mar 27 13:42 ET
19.74MMarket Cap-0.33P/E (TTM)
1.095High1.040Low86.27KVolume1.080Open1.045Pre Close91.67KTurnover0.54%Turnover RatioLossP/E (Static)18.45MShares7.50052wk High0.83P/B17.17MFloat Cap0.98552wk Low--Dividend TTM16.04MShs Float460.977Historical High--Div YieldTTM5.26%Amplitude0.985Historical Low1.062Avg Price1Lot Size
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
BioVie Stock Forum
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
BioVie (NASDAQ: BIVI) announced the acceptance of an abstract detailing their planned Phase 2 trial of bezisterim for Long COVID treatment at the Demystifying Long COVID International Conference in Barcelona. The study, fully funded by the U.S. Department of Defense, will be a double-blind, randomized, placebo-controlled tri...
📊⚡️📊
Biovie’s Upcoming Parkinson’s Disease Clinical Trial Is Fully Funded
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BioVie Inc (NASDAQ: BIVI) announced the pricing of a registered direct offering of 1,146,000 shares of common stock at $2.83 per share, aiming to raise approximately $3.2 million in gross proceeds. The offering, priced at-the-market under Nasdaq rules, is expected to close around October 29, 2024. The company plans to use the net proceeds for working capital and general corpo...
No comment yet